JFL Life Sciences Ltd

JFL Life Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

JFL Life Sciences Ltd

₹ 45.0 4.65%
26 Apr - close price
Company website NSE - SM : JFLLIFE
About

Incorporated in 2010, JFL Life Sciences Limited manufactures pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage forms tablets and capsules (general) Solid Oral Dosage forms, and Oral rehydration solutions (ORS).[1]

Key Points

Certified Pharma Manufacturer[1] JFL is a WHO–GMP certified pharmaceutical company with 320 products. Its business is organized into following product categories:
Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet and capsules (General), Oral Rehydration Solutions (ORFL)

Website NSE - SM
  • Market Cap ₹ 49.5 Cr.
  • Current Price ₹ 45.0
  • High / Low ₹ 56.0 / 36.0
  • Stock P/E 15.9
  • Book Value ₹ 30.5
  • Dividend Yield 0.00 %
  • ROCE 15.4 %
  • ROE 12.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Earnings include an other income of Rs.1.94 Cr.
  • Company has high debtors of 191 days.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023
6.00 27.59 19.24 23.58 20.69
3.99 24.24 16.84 22.05 18.03
Operating Profit 2.01 3.35 2.40 1.53 2.66
OPM % 33.50% 12.14% 12.47% 6.49% 12.86%
0.03 0.86 0.08 1.56 0.38
Interest 0.74 1.34 0.98 0.45 1.02
Depreciation 0.18 0.19 0.21 0.22 0.22
Profit before tax 1.12 2.68 1.29 2.42 1.80
Tax % 0.00% 36.94% 22.48% 25.21% 27.22%
1.12 1.69 1.00 1.81 1.31
EPS in Rs 18.12 2.11 0.91 1.65 1.19
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
31.78 30.17 32.77 33.59 42.83 44.27
30.45 28.31 30.61 28.23 38.90 40.08
Operating Profit 1.33 1.86 2.16 5.36 3.93 4.19
OPM % 4.19% 6.17% 6.59% 15.96% 9.18% 9.46%
0.00 0.03 0.09 0.89 1.64 1.94
Interest 0.75 1.16 1.23 2.08 1.42 1.47
Depreciation 0.15 0.24 0.28 0.37 0.43 0.44
Profit before tax 0.43 0.49 0.74 3.80 3.72 4.22
Tax % 27.91% 28.57% 27.03% 26.05% 24.46%
0.30 0.36 0.54 2.81 2.81 3.12
EPS in Rs 7.08 8.49 8.74 3.50 2.55 2.84
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 12%
TTM: -5%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 98%
TTM: 16%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 3%
Return on Equity
10 Years: %
5 Years: %
3 Years: 17%
Last Year: 13%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0.42 0.42 0.50 8.02 11.00 11.00
Reserves 4.59 4.95 6.38 3.27 21.27 22.58
8.41 9.33 16.82 15.85 7.18 6.99
2.73 9.63 5.31 21.12 9.61 12.64
Total Liabilities 16.15 24.33 29.01 48.26 49.06 53.21
2.48 5.05 6.50 7.13 6.80 6.69
CWIP 0.04 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00
13.63 19.28 22.51 41.13 42.26 46.52
Total Assets 16.15 24.33 29.01 48.26 49.06 53.21

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-3.00 3.21 -5.87 2.32 -9.06
-0.61 -2.76 -1.64 -0.71 0.86
3.61 -0.19 7.25 -1.46 8.07
Net Cash Flow 0.00 0.27 -0.26 0.15 -0.13

Ratios

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 110.95 153.16 131.54 215.15 191.41
Inventory Days 21.43 51.75 72.47 211.64 133.99
Days Payable 17.79 121.71 57.70 218.43 77.85
Cash Conversion Cycle 114.58 83.20 146.31 208.36 247.55
Working Capital Days 125.65 103.80 170.30 197.44 269.64
ROCE % 11.74% 10.26% 23.13% 15.44%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Sep 2023Mar 2024
67.47% 67.47% 67.47% 67.47% 67.47%
32.53% 32.53% 32.54% 32.53% 32.53%
No. of Shareholders 978921873832825

Documents

Announcements

Annual reports